English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/237291
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Pharmacological Approaches for the Modulation of the Potassium Channel KV4.x and KChIPs

AuthorsCercós, Pilar ; Peraza, Diego A.; Benito-Bueno, Ángela de; Socuéllamos, Paula G.; Aziz-Nignan, A.; Arrechaga-Estévez, D.; Beato, E.; Peña-Acevedo, E.; Albert, Armando ; Martín-Martínez, Mercedes ; Valenzuela, Carmen ; Gutiérrez-Rodríguez, Marta
Keywordsvoltage-gated potassium channels KV4
transient outward current
A-type current
potassium channel interacting proteins (KChIPs)
protein–protein interactions
KV4/KChIPs modulators
Issue Date2021
PublisherMolecular Diversity Preservation International
CitationInternational Journal of Molecular Sciences 22: 1-21 (2021)
AbstractIon channels are macromolecular complexes present in the plasma membrane and intracellular organelles of cells. Dysfunction of ion channels results in a group of disorders named channelopathies, which represent an extraordinary challenge for study and treatment. In this review, we will focus on voltage-gated potassium channels (KV), specifically on the KV4-family. The activation of these channels generates outward currents operating at subthreshold membrane potentials as recorded from myocardial cells (ITO, transient outward current) and from the somata of hippocampal neurons (ISA). In the heart, KV4 dysfunctions are related to Brugada syndrome, atrial fibrillation, hypertrophy, and heart failure. In hippocampus, KV4.x channelopathies are linked to schizophrenia, epilepsy, and Alzheimer’s disease. KV4.x channels need to assemble with other accessory subunits () to fully reproduce the ITO and ISA currents. Subunits affect channel gating and/or the traffic to the plasma membrane, and their dysfunctions may influence channel pharmacology. Among KV4 regulatory subunits, this review aims to analyze the KV4/KChIPs interaction and the effect of small molecule KChIP ligands in the A-type currents generated by the modulation of the KV4/KChIP channel complex. Knowledge gained from structural and functional studies using activators or inhibitors of the potassium current mediated by KV4/KChIPs will better help understand the underlying mechanism involving KV4-mediated-channelopathies, establishing the foundations for drug discovery, and hence their treatments.
URIhttp://hdl.handle.net/10261/237291
Identifiersissn: 1661-6596
Appears in Collections:(IIBM) Artículos
(IQFR) Artículos
(IQM) Artículos
Files in This Item:
File Description SizeFormat 
ijms-22-01419-v2.pdf6,71 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.